Intensification of insulin therapy with either LM25 or IGL improved HbA1c in Latin American patients with T2DM who had not achieved target HbA1c on once-daily basal insulin glargine with metformin and/or pioglitazone. This evidence concerns the gene INS and type 2 diabetes mellitus.